Govt May Check Import Of Key Sanitiser Ingredient

NEW DELHI : India’s trade remedies directorate has recommended the use of safeguard measures for two years on a key ingredient used in making hand sanitisers and cosmetics to check imports if they go past a specified level — marking the first time that quantitative restriction has been proposed.

In its recommendations to the government, the Director General of Trade Remedies (DGTR) noted that there has been a surge in imports, which was undercutting domestic prices.

“The domestic industry has suffered serious injury, as established by significant deterioration in its overall performance, in respect of parameters such as market share, production, sales, capacity utilisation, and profitability, which have sharply declined in the most recent period,” it said, adding that the increase was due to unforeseen situation.

While acknowledging the increase was partly driven by the demand for hand sanitisers during Covid, DGTR said that the proposed action on isopropyl alcohol could be put on hold by the government in case the pandemic flared up.

  • Related Posts

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Hyderabad: In a stern message to the pharmaceutical industry, Telangana Health Minister Damodar Rajanarsimha has ordered the Drug Control Authority (DCA) to take stringent action against companies and individuals involved…

    LOC issued against man who sold fake Ozempic worth Rs 180 crore to US firm

    New Delhi:  A lookout circular (LOC) has been issued against the man who allegedly sold fake Ozempic worth Rs 180 crore to a United States-based firm, officers have said. According…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet

    Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet

    AIIMS study finds catheter infections in hospital widespread across India

    AIIMS study finds catheter infections in hospital widespread across India

    MNCs seek restart of refurbished medical device imports

    MNCs seek restart of refurbished medical device imports